{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:51:29Z","timestamp":1782247889738,"version":"3.54.5"},"reference-count":221,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022LZY004"],"award-info":[{"award-number":["ZR2022LZY004"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,274,481"],"award-info":[{"award-number":["82,274,481"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874449"],"award-info":[{"award-number":["81874449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e28127","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T23:39:51Z","timestamp":1710805191000},"page":"e28127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8961-4743","authenticated-orcid":false,"given":"Yuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.heliyon.2024.e28127_bib1","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"issue":"10055","key":"10.1016\/j.heliyon.2024.e28127_bib2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis [published correction appears in Lancet","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ca.22980","article-title":"Rheumatoid arthritis in review: clinical, anatomical, cellular and molecular points of view","volume":"31","author":"Sharif","year":"2018","journal-title":"Clin. Anat."},{"issue":"9285","key":"10.1016\/j.heliyon.2024.e28127_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280846","article-title":"Changes in physical function over time in rheumatoid arthritis patients: a cohort study","volume":"18","author":"Santo","year":"2023","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28127_bib6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jama.2022.0786","article-title":"What is rheumatoid arthritis?","volume":"327","author":"Smith","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/BOR.0000000000000128","article-title":"Epigenetics in rheumatoid arthritis","volume":"27","author":"Klein","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e28127_bib8","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.3390\/ijms21144911","article-title":"Genetic polymorphisms associated with rheumatoid arthritis development and antirheumatic therapy response","volume":"21","author":"Mikhaylenko","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rdc.2019.01.011","article-title":"Mobile apps for rheumatoid arthritis: opportunities and challenges","volume":"45","author":"Mollard","year":"2019","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib10","first-page":"337","article-title":"Advances in the treatment of rheumatoid arthritis: costs and challenges","volume":"78","author":"Pisetsky","year":"2017","journal-title":"N. C. Med. J."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28127_bib11","first-page":"1245","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"84","author":"Wasserman","year":"2011","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.heliyon.2024.e28127_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2016.02.001","article-title":"Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis","volume":"79","author":"Kumar","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"sup2","key":"10.1016\/j.heliyon.2024.e28127_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/21691401.2018.1460373","article-title":"Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment","volume":"46","author":"Pirmardvand Chegini","year":"2018","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/15680266113139990091","article-title":"Rheumatoid arthritis: current advances in pathogenesis, diagnosis and therapy","volume":"13","author":"Haro","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e28127_bib15","article-title":"Promising therapeutic targets for treatment of rheumatoid arthritis","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.bor.0000218946.35107.36","article-title":"New concepts in the pathogenesis and treatment of rheumatoid arthritis","volume":"18","author":"Koch","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28127_bib17","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/ard.2004.033399","article-title":"Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study","volume":"64","author":"Dervieux","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11926-012-0275-1","article-title":"Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis","volume":"14","author":"Demoruelle","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.heliyon.2024.e28127_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2017.02.032","article-title":"Nanotherapeutics relieve rheumatoid arthritis","volume":"252","author":"Yang","year":"2017","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.rdc.2022.03.005","article-title":"Treatment guidelines in rheumatoid arthritis","volume":"48","author":"Singh","year":"2022","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/1573397116666201216164013","article-title":"Biomarker approach towards rheumatoid arthritis treatment","volume":"17","author":"Malhotra","year":"2021","journal-title":"Curr. Rheumatol. Rev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0036933015592761","article-title":"Advances in the management of rheumatoid arthritis","volume":"60","author":"Dale","year":"2015","journal-title":"Scot. Med. J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","article-title":"The role and therapeutic targeting of IL-6 in rheumatoid arthritis","volume":"13","author":"Narazaki","year":"2017","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fimmu.2019.00003","article-title":"Polarization of rheumatoid macrophages by TNF targeting through an IL-10\/STAT3 mechanism","volume":"10","author":"Degbo\u00e9","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.490","article-title":"IL-17-mediated mitochondrial dysfunction impairs apoptosis in rheumatoid arthritis synovial fibroblasts through activation of autophagy","volume":"8","author":"Kim","year":"2017","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28127_bib26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/biom10071002","article-title":"JAK-inhibitors for the treatment of rheumatoid arthritis: a focus on the present and an outlook on the future","volume":"10","author":"Angelini","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10753-020-01338-2","article-title":"ROS-dependent lipid peroxidation and reliant antioxidant ferroptosis-suppressor-protein 1 in rheumatoid arthritis: a covert clue for potential therapy","volume":"44","author":"Xie","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2024.e28127_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.imlet.2020.08.006","article-title":"Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis","volume":"227","author":"\u00d6zg\u00fcl \u00d6zdemir","year":"2020","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s13346-022-01225-3","article-title":"The exosome: a review of current therapeutic roles and capabilities in human reproduction","volume":"13","author":"Dimik","year":"2023","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.heliyon.2024.e28127_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41413-020-0100-9","article-title":"Exosomes: roles and therapeutic potential in osteoarthritis","volume":"8","author":"Ni","year":"2020","journal-title":"Bone Res"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/stem.3322","article-title":"Cartilage endplate stem cells inhibit intervertebral disc degeneration by releasing exosomes to nucleus pulposus cells to activate Akt\/autophagy [published correction appears in Stem Cells","volume":"39","author":"Luo","year":"2021","journal-title":"Stem Cell."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3107","article-title":"Exosomes and diabetes","volume":"35","author":"Casta\u00f1o","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12265-020-10040-5","article-title":"Cardiovascular exosomes and MicroRNAs in cardiovascular physiology and pathophysiology","volume":"14","author":"Henning","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/COH.0000000000000694","article-title":"Exosomes in HIV infection","volume":"16","author":"Chen","year":"2021","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/exd.13857","article-title":"Exosomes in chronic inflammatory skin diseases and skin tumors","volume":"28","author":"Wang","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","article-title":"Exosomes in cancer development, metastasis, and immunity","volume":"1871","author":"Zhang","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41584-020-0409-1","article-title":"PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets","volume":"16","author":"Curran","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28127_bib39","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.3390\/ijms21114015","article-title":"Anti-citrullinated protein antibodies in patients with rheumatoid arthritis: biological effects and mechanisms of immunopathogenesis","volume":"21","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/BOR.0000000000000452","article-title":"Rheumatoid arthritis and citrullination","volume":"30","author":"Darrah","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imr.12841","article-title":"Impaired T cell receptor signaling and development of T cell-mediated autoimmune arthritis","volume":"294","author":"Takeuchi","year":"2020","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib42","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1093\/rheumatology\/keab049","article-title":"Association between environmental air pollution and rheumatoid arthritis flares","volume":"60","author":"Adami","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbspin.2018.03.001","article-title":"Air pollution as a determinant of rheumatoid arthritis","volume":"86","author":"Sigaux","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.heliyon.2024.e28127_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107879","article-title":"Celastrol inhibits rheumatoid arthritis through the ROS-NF-\u03baB-NLRP3 inflammasome axis","volume":"98","author":"Jing","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib46","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/jphp.13326","article-title":"Medicinal plants used against various inflammatory biomarkers for the management of rheumatoid arthritis","volume":"72","author":"Singh","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4566851","article-title":"The ROS\/GRK2\/HIF-1\u03b1\/NLRP3 pathway mediates pyroptosis of fibroblast-like synoviocytes and the regulation of monomer derivatives of paeoniflorin","volume":"2022","author":"Hong","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib48","doi-asserted-by":"crossref","first-page":"12872","DOI":"10.4238\/2015.October.21.7","article-title":"Differential expression of COX-2 in osteoarthritis and rheumatoid arthritis","volume":"14","author":"Fan","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28127_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107890","article-title":"5-Lipoxygenase inhibitors attenuate TNF-\u03b1-induced inflammation in human synovial fibroblasts","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5114\/reum.2016.62469","article-title":"Esculetin reduces leukotriene B4 level in plasma of rats with adjuvant-induced arthritis","volume":"54","author":"Rzodkiewicz","year":"2016","journal-title":"Reumatologia"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cei.13158","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"De Luca","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12765","article-title":"Intestinal dysbiosis and probiotic applications in autoimmune diseases","volume":"152","author":"de Oliveira","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.heliyon.2024.e28127_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4835189","article-title":"Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis","volume":"2017","author":"Horta-Baas","year":"2017","journal-title":"J Immunol Res"},{"issue":"15","key":"10.1016\/j.heliyon.2024.e28127_bib54","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3390\/cells11152436","article-title":"Role of intestinal dysbiosis and nutrition in rheumatoid arthritis","volume":"11","author":"Attur","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e28127_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.763507","article-title":"The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis","volume":"11","author":"Yu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107392","article-title":"Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes","volume":"93","author":"Wu","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28127_bib57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153134","article-title":"Phytochemicals targeting matrix metalloproteinases regulating tissue degradation in inflammation and rheumatoid arthritis","volume":"66","author":"Alamgeer","year":"2020","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib59","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.3390\/ijms23052871","article-title":"Inflammation and bone metabolism in rheumatoid arthritis: molecular mechanisms of joint destruction and pharmacological treatments","volume":"23","author":"Maeda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00774-020-01159-1","article-title":"RANKL as a therapeutic target of rheumatoid arthritis [published correction appears in J Bone Miner Metab","volume":"39","author":"anaka","year":"2021","journal-title":"J. Bone Miner. Metabol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-156-5-201203060-00004","article-title":"Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial","volume":"156","author":"Bakker","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-157-4-201208210-00018","article-title":"Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis","volume":"157","author":"Pincus","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e28127_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10354-015-0344-y","article-title":"Anti-TNF in rheumatoid arthritis: an overview","volume":"165","author":"Radner","year":"2015","journal-title":"Wien Med. Wochenschr."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib64","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.clinthera.2018.04.016","article-title":"B lymphocytes in rheumatoid arthritis and the effects of anti-TNF-\u03b1 agents on B lymphocytes: a review of the literature","volume":"40","author":"Pala","year":"2018","journal-title":"Clin. Therapeut."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152059","article-title":"Effects of TNF-\u03b1 on autophagy of rheumatoid arthritis fibroblast-like synoviocytes and regulation of the NF-\u03baB signaling pathway","volume":"226","author":"Wang","year":"2021","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib66","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaad.2023.05.041","article-title":"A case-control pharmacovigilance study of TNF-alpha inhibitors and interleukin inhibitors on tuberculosis, Candida, lymphoma and suicidality using the FAERS database (2014-2020)","volume":"89","author":"Arcuri","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib67","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1574887113666180314102651","article-title":"The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes","volume":"13","author":"Ruscitti","year":"2018","journal-title":"Rev. Recent Clin. Trials"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib68","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","article-title":"The role and therapeutic targeting of IL-6 in rheumatoid arthritis","volume":"13","author":"Narazaki","year":"2017","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib69","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192048","article-title":"Interleukin-17 in rheumatoid arthritis: trials and tribulations","volume":"217","author":"Taams","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e28127_bib70","first-page":"349","article-title":"Tocilizumab in the treatment of rheumatoid arthritis and beyond","volume":"8","author":"Shetty","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5414\/CP204036","article-title":"Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials","volume":"60","author":"Sung","year":"2022","journal-title":"Int. J. Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1358\/dot.2018.54.3.2788019","article-title":"Rheumatoid arthritis: new monoclonal antibodies","volume":"54","author":"Serio","year":"2018","journal-title":"Drugs Today"},{"key":"10.1016\/j.heliyon.2024.e28127_bib73","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","article-title":"Targeting B cells and plasma cells in autoimmune diseases","volume":"9","author":"Hofmann","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108877","article-title":"B cell depletion treatment decreases Th17 cells in patients with rheumatoid arthritis","volume":"233","author":"Bounia","year":"2021","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/ard-2022-223365","article-title":"Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"82","author":"Kerschbaumer","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib76","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/annrheumdis-2019-216656","article-title":"Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis","volume":"79","author":"Kerschbaumer","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib77","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/s10165-008-0103-7","article-title":"The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis: a retrospective cohort study","volume":"18","author":"Suda","year":"2008","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/s101650050007","article-title":"Additive combination of actarit and methotrexate in the treatment of refractory rheumatoid arthritis","volume":"10","author":"Aso","year":"2000","journal-title":"Mod. Rheumatol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/BOR.0b013e328344fddb","article-title":"Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses","volume":"23","author":"Behrens","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/14397595.2020.1719607","article-title":"Efficacy and safety of tacrolimus in patients with rheumatoid arthritis - a systematic review and meta-analysis","volume":"31","author":"Kaneko","year":"2021","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2020.00073","article-title":"Iguratimod as a new drug for rheumatoid arthritis: current landscape [published correction appears in front pharmacol. 2020 apr 08;11:488]","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13075-019-1866-2","article-title":"Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study","volume":"21","author":"Wollenhaupt","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib83","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/jcph.1874","article-title":"Baricitinib: from rheumatoid arthritis to COVID-19","volume":"61","author":"Assadiasl","year":"2021","journal-title":"J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11926-018-0769-6","article-title":"Review of biosimilar trials and data on adalimumab in rheumatoid arthritis","volume":"20","author":"Zhao","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib85","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2217\/imt-2017-0155","article-title":"Etanercept for the treatment of rheumatoid arthritis","volume":"10","author":"Zhao","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.heliyon.2024.e28127_bib86","article-title":"Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: results from a 24-week post-marketing surveillance study [published online ahead of print, 2022 jul 12]","author":"Kameda","year":"2022","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib87","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00296-017-3663-z","article-title":"Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab","volume":"37","author":"Sung","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.heliyon.2024.e28127_bib88","first-page":"CD008341","article-title":"Golimumab for rheumatoid arthritis","volume":"1","author":"Singh","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e28127_bib89","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","article-title":"Tocilizumab: a review in rheumatoid arthritis [published correction appears in drugs","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.heliyon.2024.e28127_bib90","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/DDDT.S100302","article-title":"Profile of sarilumab and its potential in the treatment of rheumatoid arthritis","volume":"11","author":"Raimondo","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002359","article-title":"A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases","volume":"8","author":"Kastrati","year":"2022","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28127_bib92","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","article-title":"Anakinra for the treatment of rheumatoid arthritis: a safety evaluation","volume":"17","author":"Ram\u00edrez","year":"2018","journal-title":"Expet Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/1744666X.2019.1707664","article-title":"Canakinumab for the treatment of adult-onset Still's disease","volume":"16","author":"Sfriso","year":"2020","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib94","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2147\/DDDT.S105263","article-title":"Secukinumab for rheumatology: development and its potential place in therapy","volume":"10","author":"Koenders","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib95","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1358\/dot.2018.54.3.2788019","article-title":"Rheumatoid arthritis: new monoclonal antibodies","volume":"54","author":"Serio","year":"2018","journal-title":"Drugs Today"},{"key":"10.1016\/j.heliyon.2024.e28127_bib96","first-page":"7","article-title":"Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis","volume":"6","author":"Montepaone","year":"2014","journal-title":"Open Access Rheumatol"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28127_bib97","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-017-0775-4","article-title":"Abatacept: a review in rheumatoid arthritis","volume":"77","author":"Blair","year":"2017","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28127_bib98","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10067-019-04699-8","article-title":"A comprehensive review of rituximab therapy in rheumatoid arthritis patients","volume":"38","author":"Tavakolpour","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib99","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.18632\/oncotarget.13953","article-title":"Early detection of rheumatoid arthritis in rats and humans with 99mTc-3PRGD2 scintigraphy: imaging synovial neoangiogenesis","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/membranes12060550","article-title":"Extracellular vesicles as novel drug-delivery systems through intracellular communications","volume":"12","author":"Matsuzaka","year":"2022","journal-title":"Membranes"},{"issue":"3\u20135","key":"10.1016\/j.heliyon.2024.e28127_bib101","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00271866","article-title":"Cellular basis and oncogene expression of rheumatoid joint destruction","volume":"9","author":"Gay","year":"1989","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib102","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2232993","article-title":"A review on the current literature regarding the value of exosome miRNAs in various diseases","volume":"55","author":"Li","year":"2023","journal-title":"Ann. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib103","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.4155\/fmc-2018-0417","article-title":"Exosome manufacturing status","volume":"11","author":"Whitford","year":"2019","journal-title":"Future Med. Chem."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28127_bib104","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.7150\/thno.54004","article-title":"Exosome-inflammasome crosstalk and their roles in inflammatory responses","volume":"11","author":"Noonin","year":"2021","journal-title":"Theranostics"},{"issue":"16","key":"10.1016\/j.heliyon.2024.e28127_bib105","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.3390\/ijms22169060","article-title":"The role of exosome and the ESCRT pathway on enveloped virus infection","volume":"22","author":"Ju","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib106","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41422-020-00409-1","article-title":"RAB31 marks and controls an ESCRT-independent exosome pathway","volume":"31","author":"Wei","year":"2021","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib107","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/aps.2017.178","article-title":"Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2024.e28127_bib108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"Pegtel","year":"2019","journal-title":"Exosomes. Annu Rev Biochem."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib109","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1134\/S0006297920020054","article-title":"Lipid rafts in exosome biogenesis","volume":"85","author":"Skryabin","year":"2020","journal-title":"Biochemistry (Mosc.)"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib110","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.3390\/ijms22105346","article-title":"Exosome traceability and cell source dependence on composition and cell-cell cross talk","volume":"22","author":"Hamzah","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib111","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1566524019666190429144310","article-title":"Exosome: an emerging source of biomarkers for human diseases","volume":"19","author":"Xu","year":"2019","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib112","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1038\/s41467-021-24384-2","article-title":"Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9","volume":"12","author":"Mathieu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e28127_bib113","article-title":"Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma","volume":"265","author":"Yang","year":"2022","journal-title":"J. Proteonomics"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28127_bib114","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/14737159.2017.1356230","article-title":"Exosomal HSP60: a potentially useful biomarker for diagnosis, assessing prognosis, and monitoring response to treatment","volume":"17","author":"Caruso Bavisotto","year":"2017","journal-title":"Expert Rev. Mol. Diagn"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib115","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201904113","article-title":"ALIX- and ESCRT-III-dependent sorting of tetraspanins to exosomes","volume":"219","author":"Larios","year":"2020","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib116","first-page":"1080","article-title":"Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis","volume":"12","author":"Lin","year":"2020","journal-title":"Am J Transl Res"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib117","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","article-title":"Exosome-mediated metastasis: communication from a distance","volume":"49","author":"Wortzel","year":"2019","journal-title":"Dev. Cell"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28127_bib118","doi-asserted-by":"crossref","first-page":"R435","DOI":"10.1016\/j.cub.2018.01.059","article-title":"Exosomes and ectosomes in intercellular communication","volume":"28","author":"Meldolesi","year":"2018","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib119","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/BST20120266","article-title":"Exosomes as a novel way of interneuronal communication","volume":"41","author":"Chivet","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.heliyon.2024.e28127_bib120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-immunol-041015-055700","article-title":"Antigen presentation by extracellular vesicles from professional antigen-presenting cells","volume":"36","author":"Lindenbergh","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"615","key":"10.1016\/j.heliyon.2024.e28127_bib121","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb6981","article-title":"Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment","volume":"13","author":"Wang","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28127_bib122","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12857","article-title":"Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis","volume":"53","author":"Yue","year":"2020","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib123","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","article-title":"Exosomes in cancer development, metastasis, and immunity","volume":"1871","author":"Zhang","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib124","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12265-020-10040-5","article-title":"Cardiovascular exosomes and MicroRNAs in cardiovascular physiology and pathophysiology","volume":"14","author":"Henning","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.heliyon.2024.e28127_bib125","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6324912","article-title":"Exosome: function and application in inflammatory bone diseases","volume":"2021","author":"Hu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28127_bib126","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1080\/07388551.2020.1805406","article-title":"Improvement, scaling-up, and downstream analysis of exosome production","volume":"40","author":"Jafari","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib127","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00232-022-00260-y","article-title":"Research development on exosome separation technology","volume":"256","author":"Xu","year":"2023","journal-title":"J. Membr. Biol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib128","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10837450.2023.2202242","article-title":"Application of plant-derived exosome-like nanoparticles in drug delivery","volume":"28","author":"Barzin","year":"2023","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28127_bib129","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/cells10081959","article-title":"Mesenchymal stem cell-derived exosomes: applications in regenerative medicine","volume":"10","author":"Hade","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib130","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib131","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","article-title":"Extracellular miRNAs: from biomarkers to mediators of physiology and disease","volume":"30","author":"Mori","year":"2019","journal-title":"Cell Metabol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib132","doi-asserted-by":"crossref","first-page":"G646","DOI":"10.1152\/ajpgi.00295.2020","article-title":"Role and mechanisms of exosomal miRNAs in IBD pathophysiology","volume":"319","author":"Wani","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e28127_bib133","article-title":"Connection between radiation-regulating functions of natural products and miRNAs targeting radiomodulation and exosome biogenesis","volume":"24","author":"ang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib134","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/ijms24021337","article-title":"The machinery of exosomes: biogenesis, release, and uptake","volume":"24","author":"Krylova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib135","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib136","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet."},{"issue":"24","key":"10.1016\/j.heliyon.2024.e28127_bib137","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.3390\/ijms20246249","article-title":"Deciphering miRNAs' action through miRNA editing","volume":"20","author":"Correia de Sousa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28127_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24527","article-title":"Generation of MiRNA sponge constructs targeting multiple MiRNAs","volume":"36","author":"Jie","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.heliyon.2024.e28127_bib139","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-031-08356-3_9","article-title":"miRNA:miRNA interactions: a novel mode of miRNA regulation and its effect on disease","volume":"1385","author":"Hill","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13075-016-1178-8","article-title":"Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis","volume":"18","author":"Withrow","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e28127_bib141","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3389\/fimmu.2020.01912","article-title":"Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577640","article-title":"The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases","volume":"358","author":"Mirzaei","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.838884","article-title":"MicroRNA-mediated epigenetic regulation of rheumatoid arthritis susceptibility and pathogenesis","volume":"13","author":"Chang","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib144","doi-asserted-by":"crossref","first-page":"324","DOI":"10.31138\/mjr.32.4.324","article-title":"Plasma MicroRNAs (miR-146a, miR-103a, and miR-155) as potential biomarkers for rheumatoid arthritis (RA) and disease activity in Iranian patients","volume":"32","author":"Bagheri-Hosseinabadi","year":"2021","journal-title":"Mediterr J Rheumatol"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/09674845.2017.1343545","article-title":"Serum miR-210 and miR-155 expression levels as novel biomarkers for rheumatoid arthritis diagnosis","volume":"74","author":"Abdul-Maksoud","year":"2017","journal-title":"Br. J. Biomed. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib146","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/annrheumdis-2012-202815","article-title":"Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28127_bib147","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/1756-185X.13338","article-title":"MiR-146a levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis","volume":"21","author":"Bae","year":"2018","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib148","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/art.30115","article-title":"Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation","volume":"63","author":"Stanczyk","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.heliyon.2024.e28127_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/srep20223","article-title":"Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients","volume":"6","author":"Ogando","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28127_bib150","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.4049\/jimmunol.1800304","article-title":"Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF","volume":"201","author":"Chen","year":"2018","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib151","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s12276-022-00751-x","article-title":"Identification of novel rheumatoid arthritis-associated MiRNA-204-5p from plasma exosomes","volume":"54","author":"Wu","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib152","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12891-020-3159-y","article-title":"The inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell","volume":"21","author":"Meng","year":"2020","journal-title":"BMC Muscoskel. Disord."},{"key":"10.1016\/j.heliyon.2024.e28127_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.871096","article-title":"Labial gland mesenchymal stem cell derived exosomes-mediated miRNA-125b attenuates experimental sjogren's syndrome by targeting PRDM1 and suppressing plasma cells","volume":"13","author":"Xing","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib154","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jcp.27014","article-title":"Exosome-encapsulated miR-6089 regulates inflammatory response via targeting TLR4","volume":"234","author":"Xu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2022.01.002","article-title":"miR-223 in exosomes from bone marrow mesenchymal stem cells ameliorates rheumatoid arthritis via downregulation of NLRP3 expression in macrophages","volume":"143","author":"Huang","year":"2022","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib156","first-page":"132","article-title":"miR-205-5p in exosomes divided from chondrogenic mesenchymal stem cells alleviated rheumatoid arthritis via regulating MDM2 in fibroblast-like synoviocytes","volume":"22","author":"Ma","year":"2022","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib157","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s10020-022-00451-2","article-title":"Exosomal microRNA-140-3p from human umbilical cord mesenchymal stem cells attenuates joint injury of rats with rheumatoid arthritis by silencing SGK1","volume":"28","author":"Huang","year":"2022","journal-title":"Mol. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28127_bib158","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1039\/C9BM01761E","article-title":"Exosomal miRNA-486-5p derived from rheumatoid arthritis fibroblast-like synoviocytes induces osteoblast differentiation through the Tob1\/BMP\/Smad pathway","volume":"8","author":"Chen","year":"2020","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib159","first-page":"629","article-title":"Pro-angiogenic effect of exosomal microRNA-103a in mice with rheumatoid arthritis via the downregulation of hepatocyte nuclear factor 4 alpha and activation of the JAK\/STAT3 signaling pathway","volume":"35","author":"Chen","year":"2021","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00109-020-01882-2","article-title":"Synovial fibroblast-derived exosomal microRNA-106b suppresses chondrocyte proliferation and migration in rheumatoid arthritis via down-regulation of PDK4","volume":"98","author":"Liu","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e28127_bib161","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/1535370220934736","article-title":"Exosomes derived from synovial fibroblasts under hypoxia aggravate rheumatoid arthritis by regulating Treg\/Th17 balance","volume":"245","author":"Ding","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e28127_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105985","article-title":"Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis","volume":"78","author":"Zheng","year":"2020","journal-title":"Int. Immunopharm."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib163","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/jcb.26659","article-title":"MiR-548a-3p regulates inflammatory response via TLR4\/NF-\u03baB signaling pathway in rheumatoid arthritis","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib164","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1159\/000494793","article-title":"Circulating exosomal miR-17 inhibits the induction of regulatory T cells via suppressing TGFBR II expression in rheumatoid arthritis","volume":"50","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e28127_bib165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2018.11.009","article-title":"Exosomes in inflammation and role as biomarkers","volume":"488","author":"Console","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib166","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/cells10010120","article-title":"Role of synovial exosomes in osteoclast differentiation in inflammatory arthritis","volume":"10","author":"Song","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e28127_bib167","first-page":"1","article-title":"Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment [published correction appears in Bioact Mater","volume":"18","author":"Zhang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.heliyon.2024.e28127_bib168","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","article-title":"NF-\u03baB and the transcriptional control of inflammation","volume":"335","author":"Mitchell","year":"2018","journal-title":"Int Rev Cell Mol Biol"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib169","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1021\/acs.nanolett.0c03279","article-title":"Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-\u03baB and Notch1 pathways","volume":"20","author":"An","year":"2020","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s11658-021-00254-z","article-title":"Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy","volume":"26","author":"Zhao","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib171","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2249.1998.00701.x","article-title":"Modulation by proinflammatory cytokines of Fas\/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA)","volume":"114","author":"Wakisaka","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28127_bib172","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1007\/s11033-021-06733-y","article-title":"Impact of native and external factors on exosome release: understanding reactive exosome secretion and its biogenesis","volume":"48","author":"Hariharan","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"26","key":"10.1016\/j.heliyon.2024.e28127_bib173","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1182\/blood-2010-12-326629","article-title":"Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150","volume":"117","author":"Ghisi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e28127_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154479","article-title":"Triptolide improves chondrocyte proliferation and secretion via down-regulation of miR-221 in synovial cell exosomes","volume":"107","author":"Li","year":"2022","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib175","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib176","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An overview of autophagy: morphology, mechanism, and regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxidants Redox Signal."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib177","first-page":"950","article-title":"Expression and regulatory mechanism of autophagy-related genes in synovial tissues of patients with rheumatoid arthritis","volume":"44","author":"Chen","year":"2022","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.heliyon.2024.e28127_bib178","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1768052","article-title":"Wenhua juanbi recipe attenuates rheumatoid arthritis via inhibiting miRNA-146a-mediated autophagy","volume":"2022","author":"Zhou","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib179","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/15548627.2018.1522467","article-title":"Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1","volume":"15","author":"Li","year":"2019","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-019-1920-0","article-title":"miR-449a inhibits cell proliferation, migration, and inflammation by regulating high-mobility group box protein 1 and forms a mutual inhibition loop with Yin Yang 1 in rheumatoid arthritis fibroblast-like synoviocytes","volume":"21","author":"Cai","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib181","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00011-012-0572-1","article-title":"Reduced apoptosis correlates with enhanced autophagy in synovial tissues of rheumatoid arthritis","volume":"62","author":"Xu","year":"2013","journal-title":"Inflamm. Res."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28127_bib182","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201273","article-title":"Lnc RNA ZFAS1 regulates the proliferation, apoptosis, inflammatory response and autophagy of fibroblast-like synoviocytes via miR-2682-5p\/ADAMTS9 axis in rheumatoid arthritis","volume":"40","author":"Yang","year":"2020","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib183","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12891-020-3159-y","article-title":"The inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell","volume":"21","author":"Meng","year":"2020","journal-title":"BMC Muscoskel. Disord."},{"key":"10.1016\/j.heliyon.2024.e28127_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.809806","article-title":"Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib185","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13075-015-0892-y","article-title":"Autophagy induction contributes to the resistance to methotrexate treatment in rheumatoid arthritis fibroblast-like synovial cells through high mobility group box chromosomal protein 1","volume":"17","author":"Xu","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib186","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","article-title":"Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis","volume":"19","author":"Bustamante","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e28127_bib187","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jot.2019.07.007","article-title":"Genistein inhibits angiogenesis developed during rheumatoid arthritis through the IL-6\/JAK2\/STAT3\/VEGF signalling pathway","volume":"22","author":"Cheng","year":"2019","journal-title":"J Orthop Translat"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib188","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/art.34341","article-title":"CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1\u03b1-mediated pathway in rheumatoid arthritis","volume":"64","author":"Wang","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e28127_bib189","doi-asserted-by":"crossref","first-page":"9378","DOI":"10.1111\/jcmm.16877","article-title":"Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28127_bib190","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41419-021-04136-2","article-title":"CXCL13\/CXCR5 axis facilitates endothelial progenitor cell homing and angiogenesis during rheumatoid arthritis progression","volume":"12","author":"sai","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e28127_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174500","article-title":"Angiogenesis as a potential treatment strategy for rheumatoid arthritis","volume":"910","author":"Wang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib192","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ymthe.2017.11.016","article-title":"Hypoxic lung-cancer-derived extracellular vesicle MicroRNA-103a increases the oncogenic effects of macrophages by targeting PTEN","volume":"26","author":"Hsu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.heliyon.2024.e28127_bib193","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6403504","article-title":"Arsenic trioxide in synergy with vitamin D rescues the defective VDR-PPAR-\u03b3 functional module of autophagy in rheumatoid arthritis","volume":"2019","author":"Wang","year":"2019","journal-title":"PPAR Res."},{"key":"10.1016\/j.heliyon.2024.e28127_bib194","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.2147\/IJN.S333465","article-title":"Therapeutic potential of exosomal circRNA derived from synovial mesenchymal cells via targeting circEDIL3\/miR-485-3p\/PIAS3\/STAT3\/VEGF functional module in rheumatoid arthritis","volume":"16","author":"Zhang","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib195","first-page":"1","article-title":"Circ_0000396 inhibits rheumatoid arthritis synovial fibroblast growth and inflammatory response via miR-203\/HBP1 axis","volume":"28","author":"Wang","year":"2021","journal-title":"J. Biol. Res."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28127_bib196","first-page":"7709","article-title":"LncRNA LOC100912373 modulates PDK1 expression by sponging miR-17-5p to promote the proliferation of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"12","author":"Fan","year":"2020","journal-title":"Am J Transl Res"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib197","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14715\/cmb\/2022.68.6.28","article-title":"Rheumatoid arthritis and oxidative stress","volume":"68","author":"Zamudio-Cuevas","year":"2022","journal-title":"Cell. Mol. Biol. (Noisy-Le-Grand)"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28127_bib198","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10787-018-0514-9","article-title":"Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis","volume":"26","author":"Costa","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.heliyon.2024.e28127_bib199","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cbi.2017.12.024","article-title":"Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis","volume":"281","author":"Phull","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.heliyon.2024.e28127_bib200","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7536805","article-title":"Oxidative stress in rheumatoid arthritis: what the future might hold regarding novel biomarkers and add-on therapies","volume":"2019","author":"da Fonseca","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28127_bib201","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1007\/s11033-020-05443-1","article-title":"Exosomal miRNAs in osteoarthritis","volume":"47","author":"Mihanfar","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.heliyon.2024.e28127_bib202","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.msec.2018.04.006","article-title":"hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation","volume":"89","author":"Sun","year":"2018","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.heliyon.2024.e28127_bib203","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.omtn.2019.07.011","article-title":"Multi-pathway protective effects of MicroRNAs on human chondrocytes in an in vitro model of osteoarthritis","volume":"17","author":"Al-Modawi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28127_bib204","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yexcr.2017.09.019","article-title":"MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2\/ARE pathway through a Keap1-independent mechanism [published correction appears in Exp Cell Res. 2017 Dec 1;361(1):199]","volume":"360","author":"Liao","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.heliyon.2024.e28127_bib205","article-title":"Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect","volume":"2018","author":"Jiang","year":"2018","journal-title":"Stem Cell. Int."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib206","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000525112","article-title":"Upregulated miR-146a expression in peripheral blood relates to Th17 and Treg imbalance in elder rheumatoid arthritis patients","volume":"15","author":"Liu","year":"2022","journal-title":"Lifestyle Genom."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib207","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10571-020-00982-4","article-title":"Context-Dependent role of miR-124 in retinoic acid-induced growth cone attraction of regenerating motorneurons","volume":"42","author":"Walker","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib208","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jbmr.3005","article-title":"Synovium-derived MicroRNAs regulate bone pathways in rheumatoid arthritis","volume":"32","author":"Maeda","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28127_bib209","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.24331","article-title":"Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis","volume":"60","author":"Miller","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28127_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201851","article-title":"Small RNAs detected in exosomes derived from the MH7A synovial fibroblast cell line with TNF-\u03b1 stimulation","volume":"13","author":"Takamura","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e28127_bib211","series-title":"Book THU0059 Plasma Exosomal Mir-92a Are Involved in the Occurrence and Development of Bone Destruction in Ra Patients by Inhibiting Apoptosis of Fibroblast-like Synoviocytes","article-title":"THU0059 Plasma exosomal mir-92a are involved in the occurrence and development of bone destruction in ra patients by inhibiting apoptosis of fibroblast-like synoviocytes","author":"Xin","year":"2018"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12010-022-04090-5","article-title":"Curcumin-loaded mesenchymal stem cell-derived exosomes efficiently attenuate proliferation and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes","volume":"195","author":"He","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28127_bib213","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.4049\/jimmunol.179.4.2242","article-title":"Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4","volume":"179","author":"Kim","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib214","article-title":"Immunosuppressive exosomes: a new approach for treating arthritis","volume":"2012","author":"Yang","year":"2012","journal-title":"Internet J. Rheumatol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28127_bib215","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.4049\/jimmunol.174.10.6440","article-title":"Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis","volume":"174","author":"Kim","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28127_bib216","article-title":"Comparison of therapeutic effects of different mesenchymal stem cells on rheumatoid arthritis in mice","volume":"7","author":"Zhang","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.heliyon.2024.e28127_bib217","article-title":"Function and role of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28127_bib218","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.biochi.2013.04.017","article-title":"Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes","volume":"95","author":"Maumus","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.heliyon.2024.e28127_bib219","doi-asserted-by":"crossref","unstructured":"Mi L, Gao J, Li N, et al. Human umbilical cord mesenchymal stem cell-derived exosomes loaded miR-451a targets ATF2 to improve rheumatoid arthritis. Int. Immunopharm.. doi:10.1016\/j.intimp.2023.111365.","DOI":"10.1016\/j.intimp.2023.111365"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28127_bib220","doi-asserted-by":"crossref","DOI":"10.1080\/08916934.2023.2282939","article-title":"TNF-\u03b1 stimulated exosome derived from fibroblast-like synoviocytes isolated from rheumatoid arthritis patients promotes HUVEC migration, invasion and angiogenesis by targeting the miR-200a-3p\/KLF6\/VEGFA axis","volume":"56","author":"Zhang","year":"2023","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28127_bib221","first-page":"680","article-title":"IL-27-induced, MSC-derived exosomes promote MMP3 expression through the miR-206\/l3mbtl4 Axis in synovial fibroblasts","volume":"29","author":"Ma","year":"2023","journal-title":"Alternative Ther. Health Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024041586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024041586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:41:13Z","timestamp":1782247273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024041586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":221,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024041586"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28127","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28127"}}